Altered p-JAK1 expression is associated with estrogen receptor status in breast infiltrating ductal carcinoma

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 35-39

  Yeh, Y T ^a,b   Ou Yang, F ^b   Chen, I F ^c   Yang, S F ^b   Su, J H ^b   Hou, M F ^b,d   Yuan, S S ^a,c  

^a E DA HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Estrogen receptor; Infiltrating ductal carcinoma; p JAK1

Indexed keywords

ESTROGEN RECEPTOR; JAK1 PROTEIN, HUMAN; JANUS KINASE 1;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CANCER STAGING; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PHOSPHORYLATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; ENZYME ACTIVATION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; JANUS KINASE 1; NEOPLASM STAGING; PHOSPHORYLATION; RECEPTORS, ESTROGEN;

EID: 39049178403     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.35     Document Type: Article

References (20)

1. Rane SG and Reddy EP: JAKs, STATs and Src kinases in hematopoiesis. Oncogene 21: 3334-3358, 2002. (Pubitemid 34587707)
2. Rane SG and Reddy EP: Janus kinases: components of multiple signaling pathways. Oncogene 19: 5662-5679, 2000.
3. Boudny V and Kovarik J: JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription. Neoplasma 49: 349-355, 2002.
4. Rodig SJ, Meraz MA, White JM, et al: Disruption of the Jak1 gene demonstrates obligatory and non-redundant roles of the Jaks in cytokine-induced biologic responses. Cell 93: 373-383, 1998. (Pubitemid 28232082)
5. Campbell GS, Yu CL, Jove R and Carter-Su C: Constitutive activation of JAK1 in Src-transformed Cells. J Biol Chem 272: 2591-2594, 1997. (Pubitemid 27053296)
6. Zhang Y, Turkson J, Carter-Su C, et al: Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of JAK1 kinase activity. J Biol Chem 275: 24935-2444, 2000.
7. Sexl V, Kovacic B, Piekorz R, et al: Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation. Blood 101: 4937-4943, 2003. (Pubitemid 36857757)
8. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, et al: BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 99: 7560-7565, 2002. (Pubitemid 34568730)
9. Winston LA and Hunter T: JAK2, Ras and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J Biol Chem 270: 30837-30840, 1995. (Pubitemid 26012161)
10. Xie J, Le Baron MJ, Nevalainen MT and Rui H: Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J Biol Chem 277: 14020-14030, 2002. (Pubitemid 34968011)
11. Leung KC, Doyle N, Ballesteros M, et al: Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100: 1016-1021, 2003. (Pubitemid 36183947)
12. Proietti C, Salatino M, Rosemblit C, et al: Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol 25: 4826-4840, 2005. (Pubitemid 40781085)
13. Yuan SS, Cox LA, Dasika GK and Lee EY: Cloning and functional studies of a novel gene aberrantly expressed in RB-deficient embryos. Dev Biol 207: 62-75, 1999. (Pubitemid 29117801)
14. Yuan SS, Tsai KB, Chung YF, et al: Aberrant expression and possible involvement of the leptin receptor in endometrial cancer. Gynecol Oncol 92: 769-775, 2004.
15. Gao B, Shen X, Kunos G, et al: Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett 488: 179-184, 2001. (Pubitemid 32103593)
16. Yi T and Ihle JN: Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand. Mol Cell Biol 13: 3350-3358, 1993. (Pubitemid 23157272)
17. Yi T, Mui AL, Krystal G and Ihle JN: Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 13: 7577-7586, 1993. (Pubitemid 23354282)
18. Klingmuller U, Lorenz U, Cantley LC, Neel BG and Lodish HF: Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80: 729-738, 1995.
19. Bittorf T, Seiler J, Zhang Z, Jaster R and Brock J: SHP-1 protein tyrosine phosphatase negatively modulates erythroid differentiation and suppression of apoptosis in J2E erythroleukemic cells. Biol Chem 380: 1201-1209, 1999. (Pubitemid 29516409)
20. Yip SS, Crew AJ, Gee JM, et al: Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int J Cancer 88: 363-368, 2000.